Moleculera Biosciences Patient Stories
Infection-induced autoimmune disorder causes tics and psychosis (Nightline – Part 2)
Parker suffered from debilitating anxiety and depression. The Autoimmune Brain Panel™ (formerly known as the Cunningham Panel™) test results helped clinicians determine appropriate treatments.
Watch patients describe how the Autoimmune Brain Panel™
(formerly the Cunningham Panel™) helped changed their lives.
INVESTOR INQUIRIES
Join Moleculera Biosciences in our mission to improve the lives of those suffering from immune-mediated neuropsychiatric, cardiovascular and neurodegenerative disorders.
Investor inquiries please contact:
Craig Shimasaki, PhD, MBA President and CEO, Moleculera Biosciences shimasakic@moleculera.com
Gary Gentges Investor and Business Relations Consultant gentgesg@moleculera.com
If you would like us to contact you directly, please complete the form.